An Open-Label Exploratory Study Evaluating the Efficacy and Safety of Ingenol Mebutate Gel 0.05% for the Treatment of Verruca Vulgaris

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.137 ◽

2017 ◽

Vol 1 ◽

pp. s138

Author(s):

Neal D Bhatia

Keyword(s):

Exploratory Study ◽

Efficacy And Safety ◽

Ingenol Mebutate ◽

Verruca Vulgaris

Abstract Not Available

Download Full-text

An open-label exploratory study evaluating the efficacy and safety of ingenol mebutate gel 0.05% for the treatment of verruca vulgaris

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.08.056 ◽

2018 ◽

Vol 78 (3) ◽

pp. 595-596

Author(s):

Neal D. Bhatia

Keyword(s):

Exploratory Study ◽

Efficacy And Safety ◽

Ingenol Mebutate ◽

Verruca Vulgaris

Download Full-text

Efficacy and safety of istradefylline in patients with Parkinson's disease presenting with postural abnormalities: Results from a multicenter, prospective and open-label exploratory study in Japan

Journal of the Neurological Sciences ◽

10.1016/j.jns.2021.120078 ◽

2021 ◽

pp. 120078

Author(s):

Makio Takahashi ◽

Toshio Shimokawa ◽

Jinsoo Koh ◽

Takao Takeshima ◽

Hirofumi Yamashita ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Exploratory Study ◽

Efficacy And Safety ◽

Postural Abnormalities

Download Full-text

A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy

PLoS ONE ◽

10.1371/journal.pone.0146222 ◽

2016 ◽

Vol 11 (1) ◽

pp. e0146222 ◽

Author(s):

Alka Deshpande ◽

Harsh Toshniwal ◽

Shashank Joshi ◽

Rajendrakumar H. Jani

Keyword(s):

Exploratory Study ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: An open-label, phase 3 exploratory study

Journal of Diabetes Investigation ◽

10.1111/jdi.12730 ◽

2017 ◽

Vol 9 (2) ◽

pp. 354-359 ◽

Author(s):

Nobuya Inagaki ◽

Hiroki Sano ◽

Yoshifumi Seki ◽

Shingo Kuroda ◽

Kohei Kaku

Keyword(s):

Diabetes Mellitus ◽

Exploratory Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Open Label Phase

Download Full-text

Abstract OT3-01-10: A prospective, open-label, single-arm, multi-center, phase II exploratory study to evaluate the efficacy and safety of poziotinib (NOV120101) in patients with HER2-positive metastatic breast cancer who have received at least two prior HER2-directed regimens

10.1158/1538-7445.sabcs15-ot3-01-10 ◽

2016 ◽

Author(s):

Y-H Park ◽

KH Jung ◽

JH Sohn ◽

KS Lee ◽

KH Lee ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Exploratory Study ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Her2 Positive ◽

Download Full-text

A study protocol for evaluating the efficacy and safety of skin electrical stimulation for Leber hereditary optic neuropathy: a single-arm, open-label, non-randomized prospective exploratory study

Clinical Ophthalmology ◽

10.2147/opth.s204669 ◽

2019 ◽

Vol Volume 13 ◽

pp. 897-904 ◽

Author(s):

Takuji Kurimoto ◽

Kaori Ueda ◽

Sotaro Mori ◽

Mari Sakamoto ◽

Yuko Yamada-Nakanishi ◽

...

Keyword(s):

Electrical Stimulation ◽

Optic Neuropathy ◽

Study Protocol ◽

Exploratory Study ◽

Efficacy And Safety ◽

Leber Hereditary Optic Neuropathy ◽

Hereditary Optic Neuropathy

Download Full-text

Efficacy and safety results from AvaALL: an open-label, randomized phase III trial of standard of care (SOC) with or without continuous bevacizumab (Bev) treatment beyond progression (PD) in patients (pts) with advanced non-small-cell lung cancer (NSCLC) progressing after first-line Bev and chemotherapy (chemo)

Pneumologie ◽

10.1055/s-0037-1619221 ◽

2018 ◽

Vol 72 (S 01) ◽

pp. S39-S40

Author(s):

F Griesinger ◽

J Bennouna ◽

J de Castro Carpeno ◽

AM Dingemans ◽

F Grossi ◽

...

Keyword(s):

Lung Cancer ◽

Standard Of Care ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Treatment Beyond Progression

Download Full-text

Decision letter for "Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia"

10.1002/jbmr.4184/v1/decision1 ◽

2020 ◽

Keyword(s):

Interim Analysis ◽

Phase 2 ◽

Efficacy And Safety ◽

Download Full-text

Review for "Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia"

10.1002/jbmr.4184/v2/review2 ◽

2020 ◽

Keyword(s):

Interim Analysis ◽

Phase 2 ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and safety of switching to pasireotide LAR monotherapy or in combination with pegvisomant in acromegaly patients controlled with combination therapy of somatostatin analogues and pegvisomant (PAPE study): a prospective, open-label 48 week study

Endocrine Abstracts ◽

10.1530/endoabs.56.gp4 ◽

2018 ◽

Author(s):

Eva C Coopmans ◽

Ammar Muhammad ◽

Joseph AMJL Janssen ◽

der Lely Aart J van ◽

Sebastian JCMM Neggers

Keyword(s):

Combination Therapy ◽

Somatostatin Analogues ◽

Efficacy And Safety ◽

Download Full-text